BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21708512)

  • 1. A meta-analysis of asbestos and lung cancer: is better quality exposure assessment associated with steeper slopes of the exposure-response relationships?
    Lenters V; Vermeulen R; Dogger S; Stayner L; Portengen L; Burdorf A; Heederik D
    Environ Health Perspect; 2011 Nov; 119(11):1547-55. PubMed ID: 21708512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of mesothelioma and lung cancer risk based on Phase Contrast Microscopy (PCM) estimates of fibre exposure: an update of 2000 asbestos cohort data.
    Darnton L
    Environ Res; 2023 Aug; 230():114753. PubMed ID: 36965802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of evidence must guide risk assessment of asbestos.
    Lenters V; Burdorf A; Vermeulen R; Stayner L; Heederik D
    Ann Occup Hyg; 2012 Oct; 56(8):879-87. PubMed ID: 23002275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case control study of lung cancer and exposure to chrysotile and amphibole at a slovenian asbestos-cement plant.
    Dodic Fikfak M; Kriebel D; Quinn MM; Eisen EA; Wegman DH
    Ann Occup Hyg; 2007 Apr; 51(3):261-8. PubMed ID: 17351264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer risk at low cumulative asbestos exposure: meta-regression of the exposure-response relationship.
    van der Bij S; Koffijberg H; Lenters V; Portengen L; Moons KG; Heederik D; Vermeulen RC
    Cancer Causes Control; 2013 Jan; 24(1):1-12. PubMed ID: 23187858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
    Goodman JE; Peterson MK; Bailey LA; Kerper LE; Dodge DG
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):8-15. PubMed ID: 24189076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human evidence: lung cancer mortality risk from chrysotile exposure.
    Hughes JM
    Ann Occup Hyg; 1994 Aug; 38(4):555-60, 415-6. PubMed ID: 7978978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Hodgson JT; Darnton A
    Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse health effects of asbestos: solving mysteries regarding asbestos carcinogenicity based on follow-up survey of a Chinese factory.
    Yano E
    Environ Health Prev Med; 2018 Aug; 23(1):35. PubMed ID: 30089452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis.
    Stayner LT; Dankovic DA; Lemen RA
    Am J Public Health; 1996 Feb; 86(2):179-86. PubMed ID: 8633733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
    Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
    Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The health effects of short fiber chrysotile and amphibole asbestos.
    Bernstein DM
    Crit Rev Toxicol; 2022 Feb; 52(2):89-112. PubMed ID: 35703172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality from occupational exposure to relatively pure chrysotile: a 39-year study.
    Sichletidis L; Chloros D; Spyratos D; Haidich AB; Fourkiotou I; Kakoura M; Patakas D
    Respiration; 2009; 78(1):63-8. PubMed ID: 18843176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
    Garabrant DH; Pastula ST
    Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure of UK industrial plumbers to asbestos, Part I: Monitoring of exposure using personal passive samplers.
    Burdett G; Bard D
    Ann Occup Hyg; 2007 Mar; 51(2):121-30. PubMed ID: 17189281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis.
    Marsh GM; Riordan AS; Keeton KA; Benson SM
    Occup Environ Med; 2017 Nov; 74(11):838-846. PubMed ID: 28935666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of exposure assessment and parameterization on exposure response. Aspects of epidemiologic cohort analysis using the Libby Amphibole asbestos worker cohort.
    Bateson TF; Kopylev L
    J Expo Sci Environ Epidemiol; 2015 Jan; 25(1):12-7. PubMed ID: 24496219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tremolite asbestos exposures associated with the use of commercial products.
    Finley BL; Pierce JS; Phelka AD; Adams RE; Paustenbach DJ; Thuett KA; Barlow CA
    Crit Rev Toxicol; 2012 Feb; 42(2):119-46. PubMed ID: 22141364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.